Cancer and neoplasmsManagement of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a Neurofibromatosis Type 2 (NF-2) Patient With Vestibular Schwannoma Posted on September 29, 2023September 29, 2023 by yun 29 Sep Specialty yun Gender’s Impact on the Link Between Cardiovascular Risk Factors and Depression Penn Medicine Lancaster General Health announces October blood drives